论文部分内容阅读
目的:探讨分析小儿手足口病采用干扰素与炎琥宁联合治疗的临床疗效。方法:将我院收治的70例小儿手足口病患儿按照随机数字表法分为观察组(在综合对症治疗基础上采用干扰素与炎琥宁联合治疗)和对照组(在综合对症治疗基础上采用炎琥宁治疗),对比观察两组患儿临床症状消失时间以及临床疗效。结果:观察组患儿口腔溃疡消失时间、手足皮疹消失时间、体温下降时间、平均住院时间等明显短于对照组(P<0.05);观察组患儿治疗总有效率(97.1%)明显高于对照组(60%),差异对比具有统计学意义(P<0.05)。结论:小儿手足口病采用干扰素与炎琥宁联合治疗的临床疗效显著,可有效改善患儿的临床症状,缩短住院时间,促进患儿尽早康复,值得在临床上进一步推广、应用。
Objective: To investigate the clinical efficacy of combined treatment of interferon and mesylate in children with HFMD. Methods: Seventy children with HFMD in our hospital were divided into two groups according to the random number table: observation group (combined treatment with interferon and mesylate on the basis of comprehensive symptomatic treatment) and control group (based on comprehensive symptomatic treatment basis On the use of Yan Hu Ning treatment), comparative observation of two groups of children clinical symptoms disappear time and clinical efficacy. Results: The disappearance time of oral ulcer, disappearance of hand-foot rash, temperature decline time and average length of hospital stay in the observation group were significantly shorter than those in the control group (P <0.05). The total effective rate in the observation group was significantly higher than that in the control group (97.1%) The control group (60%), the difference was statistically significant (P <0.05). Conclusion: The clinical curative effect of combined treatment of interferon and mesylate by infantile HFMD is significant, which can effectively improve the clinical symptoms, shorten the length of hospital stay and promote the early recovery of children. It is worth further clinical application.